Frequently Asked Questions

Updating Your Prefix Registration

Name Changes

GS1 Company Prefix Transfer Requests

If the Prefix Release Letter from the selling company cannot be obtained, you will be requested to provide additional supporting documentation to demonstrate that the GS1 Company Prefix was intended to be transferred as part of the sale of a company’s business or business line or a merger. Refer to our website for additional details.

If a Prefix Release Letter from a duly authorized officer of the selling company cannot be obtained, please contact GS1 US and advise.You may instead submit signed, transactional acceptable legal documentation that evidence the sale of a business, sale of a business line or a merger. Please refer our website for additional details.

Documents that do not demonstrate the sale of a business, sale of a business line, or merger are insufficient to support the transfer of a GS1 Company Prefix.Examples of unacceptable documents include:

  • documents that purport to transfer or assignment of a GS1 Company Prefix independent of the sale of a business, sale of a business line, or merger;
  • documents evidencing the sale or transfer of intellectual property independent of the sale of a business or business line;
  • documents evidencing the sale or transfer of assets independent of the sale of a business or business line; and
  • Bill of Sale
  • documents showing the purchase or acquisition of a defunct company’s assets, whether through a foreclosure sale, tax sale, bankruptcy sale, liquidation sale, or the like. 

 

No. The information provided to GS1 US is used only to update the prefix registration. Any updates that impact the FDA Labeler Code itself need to be communicated directly to the U.S. FDA. This notification is the responsibility of the company, not GS1 US.